http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006514647-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2003-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2006514647-A |
| titleOfInvention | Antibacterial oxazolidinones |
| abstract | A compound of formula (I), or a pharmaceutically acceptable salt or in-vivo hydrolysable ester thereof: [Chemical 1] [Chemical 2] {Wherein Formula (I): C is selected from D and E; Formula (II): R 2 a, R 6 a, and R 3 a are independently selected from, for example, H, CF 3 , Me, and Et; R 2 b and R 6 b are independently selected from, for example, H, F, CF 3 , Me and Et; R 1 b is —NRz—Z where Rz is, for example, hydrogen and Z is a 5- or 6-membered heterocycle; R 4 is, for example, an optionally substituted 5- or 6-membered heterocyclic ring system}. Also described are processes for preparing compounds of formula (I), compositions containing them and use as antibacterial agents. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012505199-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009533315-A |
| priorityDate | 2002-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 373.